Author
Timothy M. Uyeki
Other affiliations: National Center for Immunization and Respiratory Diseases, University of California, San Francisco, Tulane University ...read more
Bio: Timothy M. Uyeki is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Influenza A virus subtype H5N1 & Influenza A virus. The author has an hindex of 86, co-authored 309 publications receiving 42818 citations. Previous affiliations of Timothy M. Uyeki include National Center for Immunization and Respiratory Diseases & University of California, San Francisco.
Papers published on a yearly basis
Papers
More filters
TL;DR: A case of probable Zaire Ebola virus–related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia highlights immune phenomena that could complicate management of Ebola virus Disease–related uveitis during convalescence.
Abstract: We report a case of probable Zaire Ebola virus-related ophthalmologic complications in a physician from the United States who contracted Ebola virus disease in Liberia. Uveitis, immune activation, and nonspecific increase in antibody titers developed during convalescence. This case highlights immune phenomena that could complicate management of Ebola virus disease-related uveitis during convalescence.
30 citations
TL;DR: 2 pediatric cases of neurologic illness associated with 2009 H1N1, both with favorable outcomes are described in this issue of Neurology ®.
Abstract: Each year, respiratory complications of seasonal influenza result in substantial morbidity and mortality. However, evidence continues to accrue suggesting that influenza illness is associated with severe neurologic complications, including the 2009 pandemic influenza A (H1N1) virus infection. In this issue of Neurology ®, Webster et al.1 describe 2 pediatric cases of neurologic illness associated with 2009 H1N1, both with favorable outcomes.
Rare cases of influenza-associated neurologic complications have been reported for decades. “Acute encephalopathy” was reported in association with the devastating 1918 “Spanish” influenza A (H1N1) pandemic.2 Recognition of the association of salicylate ingestion in children with influenza and development of Reye syndrome has led to preventive efforts and a dramatic decrease in this complication.3
More recently, a wide range of other neurologic illnesses associated with influenza have been described, including posterior reversible encephalopathy, myelitis, stroke, acute necrotizing encephalitis, and seizures.4–6 However, sorting out a causal role of influenza virus in many of these conditions through careful clinicopathologic investigations combined with epidemiologic studies has been challenging. Much attention has focused on influenza-associated …
30 citations
30 citations
Journal Article•
TL;DR: In this article, the effectiveness of non-pharmaceutical interventions for preventing influenza virus transmission in a cluster randomized trial of 259 people with confirmed influenza virus infection was evaluated in the US.
Abstract: Few data are available on the effectiveness of nonpharmaceutical interventions for preventing influenza virus transmission In this cluster randomized trial of 259 people with confirmed influenza v
30 citations
TL;DR: During November 2014–April 2015, a total of 165 case-patients with influenza virus A(H5N1) infection, including 6 clusters and 51 deaths, were identified in Egypt, and 99% reported poultry exposure.
Abstract: During November 2014-April 2015, a total of 165 case-patients with influenza virus A(H5N1) infection, including 6 clusters and 51 deaths, were identified in Egypt. Among infected persons, 99% reported poultry exposure: 19% to ill poultry and 35% to dead poultry. Only 1 person reported wearing personal protective equipment while working with poultry.
30 citations
Cited by
More filters
TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Abstract: Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of...
22,622 citations
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
20,189 citations
TL;DR: In this article, Anderson et al. proposed a new FAHA Chair, Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect, Alice K. Jacobs et al., this article and Biykem Bozkurt.
11,386 citations
Theo Vos1, Amanuel Alemu Abajobir, Kalkidan Hassen Abate2, Cristiana Abbafati3 +775 more•Institutions (305)
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
10,401 citations
01 Jan 2014
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Abstract: XI. STRATEGIES FOR IMPROVING DIABETES CARE D iabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Bode (Ed.): Medical Management of Type 1 Diabetes (1), Burant (Ed): Medical Management of Type 2 Diabetes (2), and Klingensmith (Ed): Intensive Diabetes Management (3). The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.
9,618 citations